Chemours vs Tronox Holdings
Chemours is the larger business, with $5.81bn of revenue in fiscal 2025 against $2.90bn for Tronox Holdings (2.0 times as much). Chemours grew faster (0.4% against -5.7%). Chemours kept more of each dollar of sales as profit: a net margin of -6.6% against -16.2%.
| Latest fiscal year | ChemoursCC, 2025 | Tronox HoldingsTROX, 2025 |
|---|---|---|
| Revenue | $5.81bn | $2.90bn |
| Revenue growth | 0.4% | -5.7% |
| Net income | −$386m | −$470m |
| Operating margin | — | — |
| Net margin | -6.6% | -16.2% |
| Return on equity | -94.0% | -29.6% |
| Free cash flow | $51.0m | −$281m |
| Cash | $670m | $199m |
| Total debt | $4.18bn | $3.25bn |
| Debt to equity | — | — |
| Dividend per share | $0.51 | $0.35 |
| Dividend yield | 2.7% | 8.0% |
| Share buybacks | — | — |
| Employees | 5,700 | 5,700 |
| Market value | $1.98bn | $553m |
| Price vs our value range | — | — |
| Moat score | 46 (Moderate) | 29 (Weak) |
| Insider trades, 12 months | 7 buys, 0 sales | 0 buys, 7 sales |